Thrombosis and thrombophilia in children: a systematic review

Daniela Tormene1, Sabrina Gavasso, Valeria Rossetto

  • 1Department of Medical and Surgical Sciences, University of Padua Medical School, Padua, Italy. daniela.tormene@unipd.it

Insights

Pediatric thrombosis is increasingly recognized, with specialized programs improving diagnosis and treatment. This review covers risk factors, prophylaxis, and thrombophilia in children, highlighting knowledge gaps due to limited pediatric trials.

Area of Science:

  • Pediatric Hematology
  • Thrombosis and Hemostasis

Background:

  • Thrombotic events in children are uncommon but increasingly recognized.
  • Advances in understanding the hemostasis system highlight the importance of thromboembolic disorders in pediatric populations.
  • Multiple underlying conditions and prothrombotic disorders contribute to childhood thrombosis.

Purpose of the Study:

  • To review current knowledge on risk factors for venous and arterial thromboembolic events in children.
  • To discuss the use of antithrombotic prophylaxis and the role of thrombophilia in pediatric patients.
  • To examine clinical manifestations and diagnostic challenges of pediatric thromboembolic and cerebrovascular diseases.

Main Methods:

  • Literature review summarizing current knowledge on pediatric thrombosis.
  • Analysis of clinical manifestations, diagnostic issues, and prophylactic strategies.
  • Discussion on the impact of prothrombotic defects and the necessity of routine testing.

Main Results:

  • Guidelines for pediatric thrombosis management often rely on adult data due to a lack of large prospective pediatric trials.
  • Specialized pediatric thrombosis programs are emerging for diagnosis, prevention, and treatment.
  • Understanding risk factors, clinical presentation, and diagnostic challenges is crucial.

Conclusions:

  • Further research and large-scale prospective trials are needed to establish evidence-based guidelines for pediatric thrombosis.
  • The role of thrombophilia testing in asymptomatic children requires careful consideration.
  • Improved understanding and management strategies are essential for addressing pediatric thromboembolic disorders.

Related Concept Videos

Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...